Karah Herdman Parschauer
Director; EVP and Chief Legal Officer · 6 filings · Latest: Jun 15, 2026
Evolus, Inc.
Tenaya Therapeutics, Inc.
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | Jun 15, 2026 | Sale | $24.62 | 1,899 | $46.8K | 94,462 | |
RARE | KARAH PARSCHAUER | — | Jun 15, 2026 | Proposed Sale | $24.35 | 3,799 | $92.5K | — | |
RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | Mar 10, 2026 | Sale | $22.67 | 3,508 | $79.5K | 66,820 | |
RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | Mar 6, 2026 | Sale | $21.40 | 6,018 | $128.8K | 70,328 | |
RARE | KARAH PARSCHAUER | — | Mar 10, 2026 | Proposed Sale | $22.67 | 3,508 | $79.5K | — | |
RARE | KARAH PARSCHAUER | — | Mar 6, 2026 | Proposed Sale | $21.40 | 6,018 | $128.8K | — | |
RARE | Karah Herdman Parschauer | EVP and Chief Legal Officer | Mar 2, 2026 | Sale | $22.80 | 8,135 | $185.5K | 76,346 | |
RARE | KARAH PARSCHAUER | — | Sep 12, 2025 | Proposed Sale | $31.17 | 2,450 | $76.4K | — | |
EOLS | Parschauer Karah Herdman | — | Mar 12, 2025 | Proposed Sale | $12.99 | 12,888 | $167.5K | — | |
RARE | Parschauer Karah Herdman | — | Feb 27, 2025 | Proposed Sale | $42.88 | 2,990 | $128.2K | — |